GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

EXPD · Jun 30, 2026

EXPEDITORS INTERNATIONAL OF WASHINGTON INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 4[email protected]
Inspectable configuration

State dimensions

Filing0001193125-26-334457General Corporate
Capex intensity25thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

0.34% · OPTIONAL · VALID

Operating cash generation15thOwn-history percentile · N=20
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

5.10% · OPTIONAL · VALID

Revenue growth75thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.revenue

32.07% · CORE · VALID

Operating margin45thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.operating_margin

9.98% · CORE · VALID

SBC intensity90thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

0.92% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History42 statesSelf-history eligible
Sep 30, 20215/5 normalizedLevel 3Dec 31, 20215/5 normalizedLevel 3Mar 31, 20225/5 normalizedLevel 3Jun 30, 20225/5 normalizedLevel 3Sep 30, 20225/5 normalizedLevel 3Dec 31, 20225/5 normalizedLevel 3Mar 31, 20235/5 normalizedLevel 3Jun 30, 20235/5 normalizedLevel 3Sep 30, 20235/5 normalizedLevel 3Dec 31, 20235/5 normalizedLevel 3Mar 31, 20245/5 normalizedLevel 3Jun 30, 20245/5 normalizedLevel 3Sep 30, 20245/5 normalizedLevel 3Dec 31, 20245/5 normalizedLevel 3Mar 31, 20255/5 normalizedLevel 3Jun 30, 20255/5 normalizedLevel 3Sep 30, 20255/5 normalizedLevel 3Dec 31, 20255/5 normalizedLevel 3Mar 31, 20265/5 normalizedLevel 3Jun 30, 20265/5 normalizedLevel 4
Period transition

What moved in the state?

Capex Intensity Decreased
Previous
0.45%
Current
0.34%
Delta
-0.11%
Cash Generation Decreased
Previous
11.11%
Current
5.10%
Delta
-6.01%
Growth Increased
Previous
4.37%
Current
32.07%
Delta
27.70%
Profitability Decreased
Previous
10.59%
Current
9.98%
Delta
-0.61%
Sbc Intensity Increased
Previous
0.46%
Current
0.92%
Delta
0.46%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Dec 31, 2018
Similarity
81%
Compared
5 dimensions
Coverage
100%
Growth 15.9 · Profitability 25.0 · Sbc Intensity 30.0 · Capex Intensity 5.0 · Cash Generation 5.0
Jun 30, 2024
Similarity
80%
Compared
5 dimensions
Coverage
100%
Growth 20.0 · Profitability 40.0 · Sbc Intensity 5.0 · Capex Intensity 5.0 · Cash Generation 5.0
Dec 31, 2024
Similarity
76%
Compared
5 dimensions
Coverage
100%
Growth 25.0 · Profitability 15.0 · Sbc Intensity 30.0 · Capex Intensity 25.0 · Cash Generation 20.0
Jun 30, 2018
Similarity
76%
Compared
5 dimensions
Coverage
100%
Growth 13.9 · Profitability 45.0 · Sbc Intensity 2.3 · Capex Intensity 9.6 · Cash Generation 23.5
Jun 30, 2020
Similarity
75%
Compared
5 dimensions
Coverage
100%
Growth 25.0 · Profitability 15.0 · Sbc Intensity 10.0 · Capex Intensity 45.0 · Cash Generation 15.0
Research Graph

Related governed research

Analogous To · EXPD state analogue 4 →Analogous To · EXPD state analogue 2 →Compared To · Arrangement Of Transportation Of Freight & Cargo peers →Analogous To · EXPD state analogue 5 →Analogous To · EXPD state analogue 3 →Analogous To · EXPD state analogue 1 →Has State · EXPEDITORS INTERNATIONAL OF WASHINGTON INC →Transitioned To · EXPD Fundamental State →Transitioned To · EXPD CAPEX_INTENSITY_DECREASED →Transitioned To · EXPD CASH_GENERATION_DECREASED →Transitioned To · EXPD GROWTH_INCREASED →Transitioned To · EXPD PROFITABILITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.